Outsourcing: Analysis and developments of contract service providers to the pharmaceutical and biotechnology industries - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Outsourcing
Contract manufacturing organizations (CMOs) and contract research organizations (CROs). Global sourcing of pharma ingredients and services. Trends and challenges for the biopharmaceutical and pharmaceutical industries.

Disposable Applications in Demand by Biopharma

November 2, 2013

Pharmaceutical Technology

Data from BioPlan Associates’ 10th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production suggest that the interest in disposable devices has begun to extend to biopharma operations beyond basic single-use bags and connectors.

Changing the Dynamic of CROs

October 2, 2013

Pharmaceutical Technology

Through its educational and networking opportunities, the American Association of Pharmaceutical Scientists plays an important role in partnering throughout the drug- development and commercialization process.

The Expense of Vision in Outsourcing

October 2, 2013

Pharmaceutical Technology

Practicality of implementation should be a part of vision in the bio/pharmaceutical industry.

Bioprocessing Advances in Vaccine Manufacture

September 4, 2013

PTSM: Pharmaceutical Technology Sourcing and Management

Advances in techniques and single-use systems are revolutionizing vaccine manufacturing.

CROs Face Issues with Talent Retention

September 4, 2013

PTSM: Pharmaceutical Technology Sourcing and Management

A recent survey shows that talent retention is an issue on industry level for contract research organizations (CROs), particularly for CROs located outside the United States.

Outsourcing Partnerships for CMC Development

September 2, 2013

Pharmaceutical Technology

Are strategic partnerships in clinical research a model for CMC services?

Making the Best of a Bad CMO-Client Relationship

September 1, 2013

Pharmaceutical Technology

A CMO perspective on the CMO-client partnership.

Gaining Insights on Contract Chemical API Manufacturing

September 1, 2013

Pharmaceutical Technology

Industry experts share their views on the outsourcing model and the current and future direction of contract chemical API manufacturing.

Charles - Genetic Assessment of Microbial Diversity in Four Geographically Separated Manufacturing Facilities in the United States

August 7, 2013

In this study, Charles River highlights the importance of environmental monitoring in trending and tracking and the awareness that each facility has its own microbial niche that contributes to product and process contamination.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
24%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
15%
Regulatory compliance
30%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Click here